SCHEMBL5190899

SCHEMBL5190899

O=c1nc(NO)ccn1[C@]1(F)O[C@H](CO)[C@@H](O)[C@H]1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 1/20 0.37
PDE3A Q14432 1/20 0.37
SLC29A1 Q99808 1/20 0.37
LMNA P02545 3/20 0.36
MTOR P42345 2/20 0.36
THRB P10828 1/20 0.36
MDM2 Q00987 1/20 0.36
NCOA1 Q15788 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
MAPT P10636 1/20 0.33
CDA P32320 1/20 0.33
P2RY6 Q15077 5/20 0.32
POLB P06746 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
ALDH1A1 P00352 2/20 0.32
GMNN O75496 1/20 0.32
TP53 P04637 1/20 0.32
NFKB1 P19838 1/20 0.32
DNMT1 P26358 1/20 0.32
THPO P40225 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15055105 0.86 MAPT (0.40) PDE4DPDE3ASLC29A1LMNAMTOR
SCHEMBL29891526 0.83 LMNA (0.36) PDE4DPDE3ASLC29A1LMNAMTOR
SCHEMBL223208 0.83 PDE3A (0.54) PDE4DPDE3ASLC29A1LMNAMTOR
Hydrochloric Acid SCHEMBL28104164 0.82 PDE3A (0.53) PDE4DPDE3ASLC29A1LMNAMTOR
SCHEMBL29891333 0.81 LMNA (0.34) PDE4DPDE3ASLC29A1LMNAMTOR
SCHEMBL29413003 0.80 LMNA (0.33) PDE4DPDE3ASLC29A1LMNAMTOR
SCHEMBL4201672 0.78 LMNA (0.43) LMNAMAPTP2RY6POLBSMN1; SMN2
SCHEMBL30919320 0.76 ADORA3 (0.35) P2RY6POLBP2RY2P2RY4
SCHEMBL23258348 0.75 PDE3A (0.56) PDE4DPDE3ASLC29A1LMNAMTOR
SCHEMBL5192208 0.74 P2RY6 (0.33) PDE4DPDE3ASLC29A1LMNAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812456-A2 ß-L-N4-HYDROXYCYTOSINE DEOXYNUCLEOSIDES AND THEIR USE AS PHARMACEUTICAL AGENTS IN THE PROPHYLAXIS OR THERAPY OF VIRAL DISEASES MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN (DE) 2007-08-01 EP disclosed
WO-2006045616-A2 β-L-N4-HYDROXYCYTOSINE DEOXYNUCLEOSIDES AND THEIR USE AS PHARMACEUTICAL AGENTS IN THE PROPHYLAXIS OR THERAPY OF VIRAL DISEASES Max-Delbrück-Centrum für Molekulare Medizin (DE) 2006-05-04 WO disclosed